Expression of A and B subunits of Shiga-like toxin II as fusions with glutathione S-transferase and their potential for use in seroepidemiology
暂无分享,去创建一个
[1] H. König,et al. The role of Escherichia coli O 157 infections in the classical (enteropathic) haemolytic uraemic syndrome: Results of a Central European, multicentre study , 1993, Epidemiology and Infection.
[2] J. Brown,et al. Antibodies to shiga holotoxin and to two synthetic peptides of the B subunit in sera of patients with Shigella dysenteriae 1 dysentery , 1992, Journal of clinical microbiology.
[3] F. Gunzer,et al. Molecular detection of sorbitol-fermenting Escherichia coli O157 in patients with hemolytic-uremic syndrome , 1992, Journal of clinical microbiology.
[4] H. Karch,et al. Indirect hemagglutination assay for diagnosis of Escherichia coli O157 infection in patients with hemolytic-uremic syndrome , 1992, Journal of clinical microbiology.
[5] F. Gunzer,et al. Molecular Detection ofSorbitol-Fermenting Escherichia coli 0157inPatients withHemolytic-Uremic Syndrome , 1992 .
[6] M. P. Jackson,et al. Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis. , 1992, Current topics in microbiology and immunology.
[7] C. Gyles,et al. Immunization of pigs with a purified Shiga-like toxin II variant toxoid. , 1991, Veterinary microbiology.
[8] E. Fikrig,et al. Molecular characterization of the humoral response to the 41-kilodalton flagellar antigen of Borrelia burgdorferi, the Lyme disease agent , 1991, Infection and immunity.
[9] M. McKee,et al. Two copies of Shiga-like toxin II-related genes common in enterohemorrhagic Escherichia coli strains are responsible for the antigenic heterogeneity of the O157:H- strain E32511 , 1991, Infection and immunity.
[10] C. Lingwood,et al. Neutralization receptor-based immunoassay for detection of neutralizing antibodies to Escherichia coli verocytotoxin 1 , 1990, Journal of clinical microbiology.
[11] H. Karch,et al. Single primer pair for amplifying segments of distinct Shiga-like-toxin genes by polymerase chain reaction , 1989, Journal of clinical microbiology.
[12] B. Rowe,et al. Serum antibodies to Escherichia coli serotype O157:H7 in patients with hemolytic uremic syndrome , 1989, Journal of clinical microbiology.
[13] M. Karmali,et al. Infection by verocytotoxin-producing Escherichia coli , 1989, Clinical Microbiology Reviews.
[14] L. Pickering,et al. Anticytotoxin-neutralizing antibodies in immune globulin preparations: potential use in hemolytic-uremic syndrome. , 1988, The Journal of pediatrics.
[15] A. O’Brien,et al. Isolation and characterization of monoclonal antibodies to Shiga-like toxin II of enterohemorrhagic Escherichia coli and use of the monoclonal antibodies in a colony enzyme-linked immunosorbent assay , 1988, Journal of clinical microbiology.
[16] H. Karch,et al. Purified verotoxins of Escherichia coli O157:H7 decrease prostacyclin synthesis by endothelial cells. , 1988, Microbial pathogenesis.
[17] H. Schägger,et al. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. , 1987, Analytical biochemistry.
[18] C. Richardson,et al. DNA sequence analysis with a modified bacteriophage T7 DNA polymerase. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[19] B. Rowe,et al. Cloning of genes determining the production of vero cytotoxin by Escherichia coli. , 1985, Journal of general microbiology.
[20] H. Lior,et al. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. , 1985, The Journal of infectious diseases.
[21] N. Tolbert,et al. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. , 1978, Analytical biochemistry.
[22] F. Sanger,et al. DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[23] C. Richardson,et al. DNA sequence analysis with a modified bacteriophage T 7 DNA polymerase ( DNA polymerase I / reverse transcriptase / chain-terminating inhibitors / 2 '-deoxyinosine 5 '-triphosphate / processivity ) , 2022 .